Understanding of the pathophysiology of thrombotic microangiopathies — a group of rare yet life-threatening hematologic conditions — has evolved in recent years along with better access to diagnostic ... This page lists all known medications that could potentially lead to 'Thrombotic thrombocytopenic purpura' as a side effect. It's important to note that mild side effects are quite common with ...

Understanding the Context

The American Journal of Managed Care: Researchers Identify Potential Risk Factors of Uncommon Thrombotic Events Following CAR T-Cell Treatment Researchers Identify Potential Risk Factors of Uncommon Thrombotic Events Following CAR T-Cell Treatment The American Journal of Managed Care: Overview of Acquired Thrombotic Thrombocytopenic Purpura X. Long Zheng, MD, PhD, gives an overview on acquired thrombotic thrombocytopenic purpura including prevalence and the typical patient presentation. X. Long Zheng, MD, PhD: What is acquired TTP?

Key Insights

TTP ... The now well-recognized risk of thrombotic events seen in patients with COVID-19 treated at various hot spots around the United States also was seen at two Cleveland Clinic sites, one in northeast ... CMAJ: Thrombotic thrombocytopenic purpura masquerading as a stroke in a young man Thrombotic microangiopathy due to thrombotic thrombocytopenia should be suspected in a patient with otherwise unexplained thrombocytopenia and anemia, even without fever, renal dysfunction or ... Excessive thrombotic complications have not been observed with the use of other compounds of this class (Table 3). For instance, few thromboembolic events have been reported in patients with cancer ...

Final Thoughts

Women with thrombotic disease and comorbid PCOS had higher rates of vascular events and presented at a younger age than those with thrombotic disease and no PCOS. Women with thrombotic disease and ... Please provide your email address to receive an email when new articles are posted on . In a case study of three patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, starting ... Transplant-associated thrombotic microangiopathy (TA-TMA) is an early complication of hematopoietic cell transplantation (HCT). A high mortality rate is documented in patients who are refractory to ...

The New England Journal of Medicine: Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination